A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Clinical trial NCT06818643 · RECRUITING
Trial details
- NCT number
- NCT06818643
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-25
- Primary completion
- 2028-10-25
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.